维普中文期刊产品整合服务
25篇 您的检索式:作者名="Pece V"
    题名 作者 年代 出处 被引量
1Retinal pigment epithelial marginal retraction atler photodynamic therapy for choroidal neovascularization in Pathologic myopia显示文摘Pece A Isola V 2008Eur J Ophthal- mol2008,18,5:1
2Aging and calorie restriction oppositely affect mitochondrial biogenesis through TFAM binding at both origins of mitochondrial DNA replication in rat liver显示文摘Picca A Pece V Fracasso F 2013PLoS One2013,8,74:1
3Efficacy and safety of anti-vascular endothelial growth factor(VEGF)therapy with Intrav-itreal ranibizumab(Lucentis)for naive retinal vein occlusion:L-year follow-up显示文摘Pece A lsola V Piermarocehi S 2011Br J Ophthalmol2011,95,1:1
4Operative management of patients previously operated upon for a benign lesion with cervical cancer as a surprise finding显示文摘Barber H R Pece G V Brunschwig A 1968Am J Obstet Gynecol1968,101,5:1
5Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascu- larization in pathologic myopia :a long-term follow-up study显示文摘PECE A VADALA M ISOLA V MATRANGA D 2007Am J Ophthalmol2007,143,3:1
6Efficacy and safety of anti-vascular endothelial growth factor(VEGF) therapy with in- travitreal ranibizumab (Lucentis) for naive retinal vein occlu- sion: 1-year follow-up 显示文摘Pece A Isola V Piermarocchi S Calori G 2011Br J Ophthalmol2011,95,1:1
7Integrating multi-criteria evaluation techniques with geographic information systems for landfill site selection: a case study using ordered weighted average 显示文摘Pece V Gorsevski Katerina R Donevska Cvetko D Mitrovski 2012Waste Man- agement2012,32,2:1
8Efficacy and safety of anti-vascular endothelial growth factor(VEGF)therapy with intravitreal ranibizumab(Lucentis)for naive retinal vein occlusion:1-year follow-up显示文摘Pece A Isola V Piermarocchi S 2011Br J Ophthalmol2011,95,1:1
9Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis显示文摘Pece S Serresi M Santolini E Capra M Hulleman E Galimberti V Zurrida S 0,,02:1
10Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion:1-year follow-up显示文摘Pece A Isola V Piermarocchi S 2011Br J Ophthalmol2011,95,1:1
11Retinal pigment epithelial marginal retraction after photodynamic therapy for choroidal neovascularization in pathologic myopia显示文摘Pece A Isola V 2008Eur J Ophthalmol2008,18,5:1
12Choroidal ischemia after photodynam- ic therapy with verteporfin for choroidal neovascularization显示文摘Isola V Pece A Parodi MB 2006Am J Ophthalmol2006,142,4:1
13Efficacy and safety of an- ti-vascular endothelial growth factor(VEGF)therapy with intravit- real ranibizumab (Lucentis)for naive retinal vein occlusion: 1-year follow-up 显示文摘Pece A Isola V Piermamcchi S 2011Br J Ophthalmol2011,95,1:1
14Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreat ranibizamab (Lucentis) for naive retinal vein occlusion 1-year follow-up 显示文摘Pece A Isola V Piermarocchi S 2011Br J Ophthalmol2011,95,1:1
15Efficacy and safty of anti-vascular endothelial growth factor(VEGF) therapy with in- travitreal ranibizumab ( Lucentis ) for naive retinal vein occlu- sion: 1-year follow-up 显示文摘Pece A Isola V Piermarocchi S Calori G 2011Br J Ophthalmol2011,95,1:1
16Breast cancer metastases are molecularly distinct from their primary tumors显示文摘Vecchi M Confalonieri S Nuciforo P Vigan5 MA Capra M Bianchi M Nicosia D Bianchi F Galimberti V Viale G Palermo G Riccardi A Campanini R Daidone M G Pierotti M A Pece S Di Fiore P P 2008Oncogene2008,27,15:1
17Efficacy and safety of anti-vas- cular endothelial growth factor(VEGF) therapy with intravitreal ranibi- zumab ( Lucentis ) for naive retinal vein occlusion : 1-year follow-up 显示文摘Pece A Isola V Piermarocchi S 2011Ophthalmol2011,95,:1
18Autofluorescence imaging of cystoid macular edema in diabetic retinopathy显示文摘Pece A Isola V Holz F 2010Opht halmologica2010,224,:1
19Photodynamic therapy with verteporfin of choroidal malignancy from breast cancer显示文摘Isola V Pece A Pierro L 2006Am J Ophthalmol2006,142,5:1
20Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab(Lucentis) for naive retinal vein occlusion:1-year follow-up显示文摘Pece A Isola V Piermarocchi S 0,,01:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费